missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human Activin RIIA Fc Chimera Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 340-R2-100/CF
Additional Details : Weight : 0.00970kg
Description
The Recombinant Human Activin RIIA Fc Chimera Protein is derived from Sf 21 (baculovirus). The Recombinant Human Activin RIIA Fc Chimera Protein has been validated for the following applications: Bioactivity.Specifications
Lyophilized from a 0.2μm filtered solution in PBS. | |
40 kDa (monomer) | |
100μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
Unconjugated | |
95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
92 | |
Activin RIIA Fc Chimera | |
Spodoptera frugiperda,Sf 21 (baculovirus)-derived human Activin RIIA protein, (N-terminus) Human Activin RIIA (Ser25-Pro134) Accession &Num; P27037 IEGRMD Human IgG1 (Pro100-Lys330) 6-His tag (C-terminus) | |
Disulfide-linked homodimer | |
Recombinant |